BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14751659)

  • 1. Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing.
    Kett MM; Denton KM; Boesen EI; Anderson WP
    Am J Hypertens; 2004 Feb; 17(2):161-6. PubMed ID: 14751659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
    Okajima K; Harada N; Uchiba M; Isobe H
    J Pharmacol Exp Ther; 2004 May; 309(2):684-91. PubMed ID: 14764656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats.
    Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Abdallah HH; Johns EJ
    Eur J Pharmacol; 2009 Jun; 612(1-3):69-74. PubMed ID: 19356722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-weaning carvedilol treatment in spontaneously hypertensive rats.
    Boesen EI; Lambert GW; Anderson WP; Kett MM
    Eur J Pharmacol; 2004 Feb; 486(2):183-8. PubMed ID: 14975707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects.
    Tanaka M; Masumura H; Tanaka S; Akashi A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S52-7. PubMed ID: 2454368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.
    Wong VY; Laping NJ; Nelson AH; Contino LC; Olson BA; Gygielko E; Campbell WG; Barone F; Brooks DP
    Br J Pharmacol; 2001 Nov; 134(5):977-84. PubMed ID: 11682445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol and the kidney.
    Dupont AG
    Clin Investig; 1992; 70 Suppl 1():S127-31. PubMed ID: 1350479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of carvedilol on chronic renal failure progression in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Dimitrijevic J; Maksic N; Djukanovic L
    Clin Nephrol; 2005 Jun; 63(6):446-53. PubMed ID: 15960146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling.
    Barone FC; Campbell WG; Nelson AH; Feuerstein GZ
    J Hypertens; 1998 Jun; 16(6):871-84. PubMed ID: 9663928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability.
    Bertera FM; Del Mauro JS; Chiappetta D; Polizio AH; Buontempo F; Taira CA; Höcht C
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Mar; 385(3):325-35. PubMed ID: 22048841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of carvedilol treatment on the effects of acetylcholine on regional haemodynamics in the spontaneously hypertensive rat.
    Granstam SO; Fellström B; Lind L
    Clin Sci (Lond); 1998 Sep; 95(3):303-9. PubMed ID: 9730849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perindopril treatment affects both preglomerular renal vascular lumen dimensions and in vivo responsiveness to vasoconstrictors in spontaneously hypertensive rats.
    Bergström G; Johansson I; Stevenson KM; Kett MM; Anderson WP
    Hypertension; 1998 Apr; 31(4):1007-13. PubMed ID: 9535428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term carvedilol therapy on renal function in essential hypertension.
    Tomita K; Marumo F
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S97-101. PubMed ID: 1378158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of uninephrectomy on renal structural properties in spontaneously hypertensive rats.
    Kinuno H; Tomoda F; Koike T; Takata M; Inoue H
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):173-8. PubMed ID: 15743399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
    Hashimoto H; Tanaka M; Kanda A; Akashi A
    Drugs; 1988; 36 Suppl 6():31-6. PubMed ID: 2908302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carvedilol on renal function.
    Dupont AG
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S96-100. PubMed ID: 1974513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of sympathetic and AT-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats.
    Abdulla MH; Sattar MA; Khan MA; Abdullah NA; Johns EJ
    Acta Physiol (Oxf); 2009 Mar; 195(3):397-404. PubMed ID: 19183357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.